ARCHIVES

Monitoring of Clinical Trials Finds Two Major Problems; Investigators Are Suspended

This article is from The Cancer Letter archive.

Vol. 09 No. 33 | August 19, 1983

Download PDF Visit The Full Archive

Related Articles

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

August 28, 2009

AMA Anti-Tobacco, Stop-Smoking Program Uses TV Marketing

April 15, 1994

In Brief: ACCC Honors Henry Lynch; Gunderson Names Chair, Mayo Oncology Department

October 11, 1996

FDA News: Rep. Barton Expresses “Concern” About Plan To Merge Offices

May 22, 1998

PV-10 Produces 51 Percent Response Rate in Phase II Trial

October 26, 2012

Flat NIH Budget Threatens Future Of Research, Universities Say.

March 14, 2008